A pyrrole-imidazole (PI) polyamide specifically designed to bind to the activator protein-1 (AP-1) site on the MMP-9 (Figure 5) promoter was developed and synthesized as a gene-silencing agent aimed at combating tumor metastases. Here, MMP9 is linked to neoplasm.